Literature DB >> 170954

On the lack of response to catecholamine stimulation by the adenyl cyclase system in psoriatic lesions.

K Yoshikawa, K Adachi, K M Halprin, V Levine.   

Abstract

When epidermis from the uninvolved skin of psoriatic patients was incubated for 5 min in Hank's medium containing adrenaline and theophylline, the cyclic AMP level consistently increased 20-30 times over the level observed when adrenaline was not added to the medium. On the other hand, when epidermis from the involved skin of psoriatic patients was incubated under the same experimental conditions, the cyclic AMP level increased only 2-5 times. Even when theophylline, and inhibitor of specific cyclic AMP-phosphodiesterase, was omitted from the medium, a clearly demonstrable difference in sensitivity to adrenaline was evident in normal appearing and lesional psoriatic epidermis. These results indicate a faulty adenyl cyclase system in the involved epidermis of psoriatic lesions rather than a defective degradation process by the specific phosphodiesterase. Since the Km for adrenaline activation of adenyl cyclase was approximately the same in both the uninvolved and the involved epidermis and since the cyclic AMP increase by adrenaline was abolished by the addition of propranolol, the basic nature of the beta-receptor (specifically the binding affinity to adrenaline) in the involved epidermis does not appear to be defective. On the other hand, the finding that the Vmax for adrenaline activation is 10-20 times higher in the uninvolved than in the involved epidermis suggests that the poor response in the involved epidermis may be due to fewer available binding sites for adrenaline in the psoriatic lesion.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170954     DOI: 10.1111/j.1365-2133.1975.tb03140.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  Immunohistochemical study of beta-adrenergic receptors in the psoriatic epidermis using an anti-alprenolol anti-idiotypic antibody.

Authors:  S Itami; J Kino; K M Halprin; K Adachi
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

2.  High density of beta 2-adrenoceptors in a human keratinocyte cell line with complete epidermal differentiation capacity (HaCaT).

Authors:  V Steinkraus; C Körner; M Steinfath; H Mensing
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

3.  Increased prevalence of early repolarization in electrocardiograms of psoriatic patients.

Authors:  Mario Mastrolonardo; Girolamo D'Arienzo; Massimo Grimaldi; Marica Caivano; Domenico Bonamonte; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Heart Vessels       Date:  2014-12-31       Impact factor: 2.037

4.  Cyclosporin A induced augmentation of the beta-adrenergic adenylate cyclase response of pig epidermis.

Authors:  N Kato; K M Halprin; J R Taylor; A Ohkawara
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

5.  Enhanced expression of ras gene products in psoriatic epidermis.

Authors:  H Kobayashi; H Yasuda; A Ohkawara; H Dosaka; A Oda; Y Ogiso; N Kuzumaki
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

6.  A Tissue-Engineered Human Psoriatic Skin Model to Investigate the Implication of cAMP in Psoriasis: Differential Impacts of Cholera Toxin and Isoproterenol on cAMP Levels of the Epidermis.

Authors:  Mélissa Simard; Sophie Morin; Geneviève Rioux; Rachelle Séguin; Estelle Loing; Roxane Pouliot
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.